Agency Information Collection Activities: Proposed Collection; Comment Request, 21984-21985 [2012-8798]
Download as PDF
21984
Federal Register / Vol. 77, No. 71 / Thursday, April 12, 2012 / Notices
group practice; group practice employer
identification number; names and DEA
registration numbers of group
practitioners; purpose of notification
new, immediate, or renewal;
certification of qualifying criteria for
treatment and management of opiate
dependent patients; certification of
capacity to refer patients for appropriate
counseling and other appropriate
ancillary services; certification of
maximum patient load, certification to
use only those drug products that meet
the criteria in the law. The form also
notifies practitioners of Privacy Act
considerations, and permits
practitioners to expressly consent to
disclose limited information to the
SAMHSA Buprenorphine Physician
Locator.
Since July 2002, SAMHSA has
received over 25,000 notifications and
has certified almost 27,000 physicians.
Fifty-one percent of the notifications
were submitted by mail or by facsimile,
with approximately forty-one percent
submitted through the Web based online
Purpose of
submission
Number of
respondents
system. Approximately 60 percent of the
certified physicians have consented to
disclosure on the SAMHSA
Buprenorphine Physician Locator.
Respondents may submit the form
electronically, through a dedicated Web
page that SAMHSA will establish for the
purpose, as well as via U.S. mail.
There are no changes to the forms and
burden hours.
The following table summarizes the
estimated annual burden for the use of
this form.
Burden per
response
(hr.)
Responses per
respondent
Total Burden
(hrs.)
Initial Application for Waiver ............................................................
Notification to Prescribe Immediately ..............................................
Notice to Treat up to 100 patients ...................................................
1,500
50
500
1
1
1
.083
.083
.040
125
4
20
Total .................................................................................................
2,050
............................
............................
149
Written comments and
recommendations concerning the
proposed information collection should
be sent by May 14, 2012, to the
SAMHSA Desk Officer at the Office of
Information and Regulatory Affairs,
Office of Management and Budget
(OMB). To ensure timely receipt of
comments, and to avoid potential delays
in OMB’s receipt and processing of mail
sent through the U.S. Postal Service,
commenters are encouraged to submit
their comments to OMB via email to:
OIRA_Submission@omb.eop.gov.
Although commenters are encouraged to
send their comments via email,
commenters may also fax their
comments to: 202–395–7285.
Commenters may also mail them to:
Office of Management and Budget,
Office of Information and Regulatory
Affairs, New Executive Office Building,
Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2012–8797 Filed 4–11–12; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
VerDate Mar<15>2010
16:27 Apr 11, 2012
Jkt 226001
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Minority AIDS
Initiative (MAI) Rapid HIV Testing
Clinical Information Form (OMB No.
0930–0295)—Revision
This request is for a three-year generic
clearance to continue rapid HIV testing
data collection among 63 TCE–HIV
Grantees and their clients and the
additional 11 MAI–HIV Grantees and
their clients. The primary purpose of the
MAI Rapid HIV Testing Clinical
Information Form is to use a
standardized data collection instrument
to fully capture essential clinical
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
information to enhance preventive
services for those who test HIV-negative
and refer to quality treatment/medical
care those who test HIV-positive.
The aim of the project is to implement
and increase rapid HIV testing among
racial and ethnic minorities and collect
rapid HIV testing data using the MAI
Rapid HIV Testing Clinical Information
Form. To meet this requirement, all
Grantees must offer their clients rapid
HIV preliminary antibody testing during
outreach, pretreatment, or program
enrollment. In addition, rapid HIV
testing may be made available to the
sexual and/or injection partners of
clients. Grantees must provide onsite
rapid HIV testing in accordance with
their respective State and local
requirements. If a client requests an offsite rapid HIV test, the Grantee must
provide a referral to a rapid HIV testing
site certified by the local health
department.
Grantees are currently using the MAI
Rapid HIV Testing Clinical Information
Form in the field to systematically
collect information from clients on
demographics, previous rapid HIV test
results, substance use and sexual risk
behaviors, current rapid HIV test results,
types of services received, and
confirmatory HIV test result. Once a
client is offered a rapid HIV test, the
Grantee staff completes the MAI Rapid
HIV Testing Clinical Information Form
with the client present and then enters
the data into a secure Web site that
allows for real-time data submission.
The estimated annualized burden is
summarized below.
E:\FR\FM\12APN1.SGM
12APN1
21985
Federal Register / Vol. 77, No. 71 / Thursday, April 12, 2012 / Notices
Estimated
number of
respondents
Respondents
MAI Rapid HIV Testing Clinical Information Form (FY 2008 and FY 2009—
63 Grantees) ................................................................................................
RHT form for 11 HIV program FY 2011 grantees (public health departments) ..........................................................................................................
MAI Rapid HIV Testing Clinical Information Form (Re-test) ...........................
Summer King,
Statistician.
[FR Doc. 2012–8798 Filed 4–11–12; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities; Proposed Collection;
Comment Request
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Average
burden hours
per response
Estimated total
burden hours
10,000
1
0.133
1,330
20,000
6,000
Total ..........................................................................................................
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 8–1099, One Choke Cherry Road,
Rockville, MD 20857 or email a copy to
summer.king@samhsa.hhs.gov. Written
comments must be received before 60
days after the date of the publication in
the Federal Register.
Estimated
number of
responses per
respondent
1
1
0.133
0.133
2,660
798
30,000
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: 2013 National Survey
on Drug Use and Health—(OMB No.
0930–0110)—Revision
The National Survey on Drug Use and
Health (NSDUH) is a survey of the
civilian, non-institutionalized
population of the United States 12 years
old and older. The data are used to
determine the prevalence of use of
tobacco products, alcohol, illicit
substances, and illicit use of
prescription drugs. The results are used
by SAMHSA, ONDCP, Federal
government agencies, and other
organizations and researchers to
establish policy, direct program
activities, and better allocate resources.
4,788
Data from clinical interviews
completed in 2008 were combined with
the main interview short scale data to
develop a predictive model that was
applied to the full main sample to
estimate SMI. Follow-up clinical
interviews continued to be conducted
with NSDUH respondents from 2009 to
2012. Data from these interviews were
analyzed annually to update the
calibration of the screening measure. To
maximize trend validity, this model has
been applied to 2009–2011 data. With
the completion of 1500 clinical
interviews in 2012, SAMHSA will have
accumulated a large enough sample
(4,500) to update and improve the
models. Therefore, the MHSS clinical
interviewing will be discontinued in
2013.
For the 2013 NSDUH, a few
questionnaire changes are proposed.
The instrument has been updated to
include new questions on military
service, medical marijuana, physician
substance use screening, and
respondent characteristics.
As with all NSDUH/NHSDA surveys
conducted since 1999, the sample size
of the survey for 2013 will be sufficient
to permit prevalence estimates for each
of the fifty states and the District of
Columbia. The total annual burden
estimate is shown below:
ESTIMATED BURDEN FOR 2013 NSDUH
Responses
per
respondent
Number of
respondents
Instrument
Hours per
response
Total burden
hours
Hourly wage
rate
Annualized
costs
145,474
67,500
5,400
10,125
1
1
1
1
0.083
1.000
0.067
0.067
12,074
67,500
362
678
$14.45
14.45
14.45
14.45
$174,469
975,375
5,231
9,797
Total ..................................................
mstockstill on DSK4VPTVN1PROD with NOTICES
Household Screening ...............................
Interview ...................................................
Screening Verification ..............................
Interview Verification ................................
145,474
........................
........................
80,614
........................
1,164,872
VerDate Mar<15>2010
16:27 Apr 11, 2012
Jkt 226001
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
E:\FR\FM\12APN1.SGM
12APN1
Agencies
[Federal Register Volume 77, Number 71 (Thursday, April 12, 2012)]
[Notices]
[Pages 21984-21985]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-8798]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Minority AIDS Initiative (MAI) Rapid HIV Testing
Clinical Information Form (OMB No. 0930-0295)--Revision
This request is for a three-year generic clearance to continue
rapid HIV testing data collection among 63 TCE-HIV Grantees and their
clients and the additional 11 MAI-HIV Grantees and their clients. The
primary purpose of the MAI Rapid HIV Testing Clinical Information Form
is to use a standardized data collection instrument to fully capture
essential clinical information to enhance preventive services for those
who test HIV-negative and refer to quality treatment/medical care those
who test HIV-positive.
The aim of the project is to implement and increase rapid HIV
testing among racial and ethnic minorities and collect rapid HIV
testing data using the MAI Rapid HIV Testing Clinical Information Form.
To meet this requirement, all Grantees must offer their clients rapid
HIV preliminary antibody testing during outreach, pretreatment, or
program enrollment. In addition, rapid HIV testing may be made
available to the sexual and/or injection partners of clients. Grantees
must provide onsite rapid HIV testing in accordance with their
respective State and local requirements. If a client requests an off-
site rapid HIV test, the Grantee must provide a referral to a rapid HIV
testing site certified by the local health department.
Grantees are currently using the MAI Rapid HIV Testing Clinical
Information Form in the field to systematically collect information
from clients on demographics, previous rapid HIV test results,
substance use and sexual risk behaviors, current rapid HIV test
results, types of services received, and confirmatory HIV test result.
Once a client is offered a rapid HIV test, the Grantee staff completes
the MAI Rapid HIV Testing Clinical Information Form with the client
present and then enters the data into a secure Web site that allows for
real-time data submission.
The estimated annualized burden is summarized below.
[[Page 21985]]
----------------------------------------------------------------------------------------------------------------
Estimated
Estimated number of Average burden Estimated
Respondents number of responses per hours per total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
MAI Rapid HIV Testing Clinical Information Form 10,000 1 0.133 1,330
(FY 2008 and FY 2009--63 Grantees).............
RHT form for 11 HIV program FY 2011 grantees 20,000 1 0.133 2,660
(public health departments)....................
MAI Rapid HIV Testing Clinical Information Form 6,000 1 0.133 798
(Re-test)......................................
---------------------------------------------------------------
Total....................................... 30,000 .............. .............. 4,788
----------------------------------------------------------------------------------------------------------------
Send comments to Summer King, SAMHSA Reports Clearance Officer,
Room 8-1099, One Choke Cherry Road, Rockville, MD 20857 or email a copy
to summer.king@samhsa.hhs.gov. Written comments must be received before
60 days after the date of the publication in the Federal Register.
Summer King,
Statistician.
[FR Doc. 2012-8798 Filed 4-11-12; 8:45 am]
BILLING CODE 4162-20-P